RDUS Radius Health, Inc. Stock Quote

RDUS [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-2.43	Insider Own	16.00%	Shs Outstand	46.49M	Perf Week	-0.43%
Market Cap	853.64M	Forward P/E	-	EPS next Y	-0.81	Insider Trans	7.27%	Shs Float	46.46M	Perf Month	-4.37%
Income	-112.50M	PEG	-	EPS next Q	-0.42	Inst Own	-	Short Float	12.17%	Perf Quarter	13.96%
Sales	231.50M	P/S	3.69	EPS this Y	40.80%	Inst Trans	2.20%	Short Ratio	12.82	Perf Half Y	54.83%
Book/sh	-2.34	P/B	-	EPS next Y	64.80%	ROA	-56.90%	Target Price	22.14	Perf Year	-5.68%
Cash/sh	2.74	P/C	6.79	EPS next 5Y	29.60%	ROE	134.60%	52W Range	10.15 - 23.84	Perf YTD	4.20%
Dividend	-	P/FCF	-	EPS past 5Y	6.50%	ROI	-73.20%	52W High	-21.94%	Beta	0.91
Dividend %	-	Quick Ratio	2.20	Sales past 5Y	-	Gross Margin	92.60%	52W Low	83.33%	ATR	1.36
Employees	383	Current Ratio	2.20	Sales Q/Q	66.20%	Oper. Margin	-37.80%	RSI (14)	42.16	Volatility	7.73% 6.93%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	79.20%	Profit Margin	-48.60%	Rel Volume	0.91	Prev Close	19.03
Shortable	Yes	LT Debt/Eq	-	Earnings	Feb 25 BMO	Payout	-	Avg Volume	440.82K	Price	18.61
Recom	2.60	SMA20	-7.90%	SMA50	-7.10%	SMA200	24.79%	Volume	401,441	Change	-2.21%

Feb-24-21

Reiterated

H.C. Wainwright

Neutral

$22 → $25

Sep-29-20

Resumed

JP Morgan

Neutral

$23

Jul-08-20

Downgrade

SVB Leerink

Outperform → Mkt Perform

$17

May-13-20

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$20

Apr-24-20

Initiated

Stifel

Hold

$20

Aug-29-19

Upgrade

Citigroup

Neutral → Buy

$24 → $40

May-30-19

Resumed

Citigroup

Neutral

May-29-19

Upgrade

Goldman

Neutral → Buy

Feb-14-19

Initiated

H.C. Wainwright

Neutral

$22

Mar-29-18

Initiated

Leerink Partners

Outperform

$53

Jan-29-18

Initiated

Morgan Stanley

Overweight

$57

Dec-06-17

Initiated

Citigroup

Neutral

$30

Oct-06-17

Resumed

Goldman

Neutral

Mar-24-17

Reiterated

H.C. Wainwright

Buy

$71 → $66

Sep-21-16

Reiterated

H.C. Wainwright

Buy

$55 → $71

Aug-04-16

Downgrade

Maxim Group

Hold → Sell

$24

May-23-16

Initiated

H.C. Wainwright

Buy

$55

Mar-30-16

Initiated

Goldman

Neutral

Feb-24-16

Downgrade

Jefferies

Buy → Hold

Oct-02-15

Initiated

JP Morgan

Overweight

$88

Feb-26-21 12:08PM	Radius' (RDUS) Q4 Loss Wider Than Expected, Revenues Beat Zacks
08:58AM	Pacira's (PCRX) Q4 Earnings Top Estimates, Revenues Miss Zacks
Feb-25-21 05:01PM	Radius Health (RDUS) Q4 2020 Earnings Call Transcript Motley Fool
07:00AM	Radius Health, Inc.: Fourth Quarter and Full Year Results GlobeNewswire
Feb-17-21 08:30AM	Radius Health to Present at 10th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-16-21 08:30AM	Radius Health to Announce Fourth Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Thursday, February 25, 2021 GlobeNewswire
Feb-12-21 12:33PM	Radius Health, Inc. Provides Abaloparatide Business Update GlobeNewswire
09:32AM	5 Small Drug Stocks to Buy Amid Lingering COVID-Led Uncertainty Zacks
Feb-09-21 09:29AM	What's in Store for Pacific Biosciences' (PACB) Q4 Earnings? Zacks -5.14%
06:28AM	Radius Health, Inc.'s (NASDAQ:RDUS) Shift From Loss To Profit Simply Wall St.
Jan-25-21 10:34AM	Aurinia (AUPH) Gets FDA Nod for Kidney Disorder Drug Lupkynis Zacks
Jan-07-21 11:05AM	Radius (RDUS) to Acquire Rights for Cannabidiol Oral Solution Zacks
Jan-06-21 12:00PM	Radius Health to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire +15.76%
10:13AM	Radius (RDUS) Inks Deal for Tymlos in Canada With Paladin Labs Zacks
06:00AM	Radius Health, Inc. Announces Acquisition of Orphan Disease Program GlobeNewswire
Jan-05-21 08:36AM	Endo Announces Licensing Agreement for Paladin Labs Inc. to Commercialize Abaloparatide in Canada PR Newswire
08:15AM	Radius Health Announces Commercial Agreement with Paladin Labs for Abaloparatide in Canada GlobeNewswire
Jan-04-21 04:30PM	Radius Health Announces Change to its Board of Directors GlobeNewswire
Dec-18-20 09:30PM	Is RDUS A Good Stock To Buy According To Hedge Funds? Insider Monkey
Dec-15-20 09:00AM	Radius Health, Inc. Provides Business Update GlobeNewswire +5.10%
Dec-05-20 11:32AM	Radius Health (RDUS) Up 3.7% Since Last Earnings Report: Can It Continue? Zacks
Nov-09-20 10:21AM	Radius' (RDUS) Q3 Loss Matches Estimates, Revenues Miss Zacks
07:39AM	Radius Health, Inc. (NASDAQ:RDUS) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? Simply Wall St.
Nov-05-20 10:32PM	Radius Health (RDUS) Q3 2020 Earnings Call Transcript Motley Fool
09:45AM	Radius Health (RDUS) Reports Q3 Loss, Misses Revenue Estimates Zacks
08:00AM	Radius Health, Inc.: Third Quarter 2020 Operating Results GlobeNewswire
06:30AM	Radius Health, Inc. to Host Earnings Call ACCESSWIRE
Oct-29-20 12:35PM	Radius Health (RDUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-21-20 08:15AM	Radius Health, Inc.: Progress Since May 2020 GlobeNewswire
Oct-20-20 04:15PM	Radius Health to Announce Third Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Thursday, November 5, 2020 GlobeNewswire
Oct-06-20 04:30PM	Peter A. Schwartzman Joins Radius Health, Inc. GlobeNewswire
02:07PM	Would Shareholders Who Purchased Radius Health's (NASDAQ:RDUS) Stock Five Years Be Happy With The Share price Today? Simply Wall St.
Oct-05-20 12:46PM	Is Radius Health Inc (RDUS) Going to Burn These Hedge Funds? Insider Monkey +7.50%
Oct-01-20 08:45AM	Radius Health Divests RAD 140 Program to Ellipses Pharma GlobeNewswire
Sep-25-20 06:15AM	Radius Health & Menarini Group Provide Elacestrant Update PR Newswire
05:51AM	Radius Health & Menarini Group Provide Elacestrant Update PR Newswire
05:51AM	Radius Health & Menarini Group Provide Elacestrant Update CNW Group
Sep-24-20 04:15PM	Radius Health & Menarini Group Provide Elacestrant Update GlobeNewswire
08:15AM	Radius Health Provides Business Update GlobeNewswire
Sep-09-20 11:30AM	Why Is Radius Health (RDUS) Down 7% Since Last Earnings Report? Zacks
07:45AM	Radius Health Announces Scientific Presentations on abaloparatide at ASBMR 2020 Annual Meeting GlobeNewswire
Sep-08-20 08:00AM	Radius Health: Enrollment Completed for Phase 3 wearABLe trial GlobeNewswire
Sep-02-20 04:15PM	Radius Health to Participate in the Citi 15th Annual BioPharma Virtual Conference and Morgan Stanley Virtual 18th Annual Global Healthcare Conference GlobeNewswire
Aug-25-20 09:00AM	Radius Health Provides Business Update GlobeNewswire
Aug-10-20 09:01PM	Radius Health (RDUS) Q2 2020 Earnings Call Transcript Motley Fool
09:35AM	Radius Health (RDUS) Reports Q2 Loss, Tops Revenue Estimates Zacks
08:44AM	Radius Health: Q2 Earnings Insights Benzinga
08:15AM	Sean Murphy joins Radius Health Board of Directors GlobeNewswire
08:15AM	Radius Health Announces Second Quarter 2020 Operating Results GlobeNewswire
Aug-03-20 12:31PM	Analysts Estimate Radius Health (RDUS) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-27-20 04:15PM	Radius Health to Announce Second Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Monday, August 10, 2020 GlobeNewswire
Jul-24-20 07:15AM	The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs Benzinga +8.97%
Jul-23-20 04:15PM	Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant GlobeNewswire
Jul-17-20 10:54AM	Did Hedge Funds Make The Right Call On Radius Health Inc (RDUS)? Insider Monkey
Jun-16-20 10:44AM	Do Hedge Funds Love Radius Health Inc (RDUS)? Insider Monkey
Jun-10-20 05:07PM	Edited Transcript of RDUS earnings conference call or presentation 7-May-20 8:45pm GMT Thomson Reuters StreetEvents
Jun-06-20 11:31AM	Why Is Radius Health (RDUS) Down 11.6% Since Last Earnings Report? Zacks
May-27-20 05:00AM	Pivotal Phase III trial of abaloparatide-SC in Japanese women and men with osteoporosis achieves primary endpoint GlobeNewswire
May-08-20 04:46PM	Radius' (RDUS) Q1 Earnings Miss Estimates, Sales Surpass Zacks
12:32PM	Radius Health (RDUS) Q1 2020 Earnings Call Transcript Motley Fool
May-07-20 04:15PM	Radius Health Announces First Quarter 2020 Operating Results GlobeNewswire +6.68%
Apr-30-20 12:34PM	Radius Health (RDUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Apr-28-20 04:35PM	Radius Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire -5.78%
04:30PM	Radius Health Announces CEO Leadership Transition GlobeNewswire
Apr-20-20 04:15PM	Radius Health to Announce First Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Thursday May 7, 2020 GlobeNewswire
Apr-08-20 12:13PM	An Intrinsic Calculation For Radius Health, Inc. (NASDAQ:RDUS) Suggests It's 33% Undervalued Simply Wall St.
Mar-28-20 11:30AM	Radius Health (RDUS) Down 33.3% Since Last Earnings Report: Can It Rebound? Zacks
Mar-03-20 09:15AM	Radius Health to Present at Cowen 40th Annual Healthcare Conference GlobeNewswire
07:33AM	Edited Transcript of RDUS earnings conference call or presentation 27-Feb-20 1:00pm GMT Thomson Reuters StreetEvents
Mar-02-20 07:47AM	Radius (RDUS) Q4 Earnings Beat Estimates on Tymlos Strength Zacks
Feb-27-20 09:05AM	Radius Health (RDUS) Reports Q4 Loss, Tops Revenue Estimates Zacks +10.41%
07:30AM	Radius Health Announces Fourth Quarter and Full-Year 2019 Operating Results GlobeNewswire
Feb-26-20 08:36AM	Is a Surprise Coming for Radius Health (RDUS) This Earnings Season? Zacks
Feb-25-20 11:28AM	Does Radius Health, Inc. (NASDAQ:RDUS) Have A Volatile Share Price? Simply Wall St. -6.14%
Feb-20-20 12:31PM	Earnings Preview: Radius Health (RDUS) Q4 Earnings Expected to Decline Zacks
Feb-13-20 04:05PM	Radius Health to Present at 9th Annual SVB Leerink Partners Global Healthcare Conference GlobeNewswire
04:05PM	Radius Health to Announce Fourth Quarter and Full Year 2019 Financial Results, Host Conference Call and Live Webcast on Thursday, February 27, 2020 GlobeNewswire
Jan-22-20 06:36AM	Moving Average Crossover Alert: Radius Health Zacks
Jan-13-20 09:00AM	Radius Exceeds 2019 Financial Guidance and Provides Business Update at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire -5.51%
Jan-09-20 01:30PM	Is Radius Health, Inc.'s (NASDAQ:RDUS) CEO Salary Justified? Simply Wall St.
Jan-06-20 04:14PM	Radius Health to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
09:13AM	Radius Health Is in Oversold Territory: What???s Next? Zacks
Dec-12-19 09:36AM	Amgen's Osteoporosis Drug Evenity Gets Approval in Europe Zacks
Dec-10-19 03:38PM	Is Radius Health Inc (RDUS) A Good Stock To Buy? Insider Monkey
Dec-06-19 09:47AM	Radius Health Announces Scientific Presentations at 2019 San Antonio Breast Cancer Symposium (SABCS) GlobeNewswire
Dec-05-19 11:31AM	Why Is Radius Health (RDUS) Down 6.9% Since Last Earnings Report? Zacks
Dec-02-19 04:52PM	Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Nov-15-19 04:15PM	Radius Health to Present at Jefferies 2019 Global Healthcare Conference in London GlobeNewswire
Nov-09-19 10:21AM	Edited Transcript of RDUS earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-06-19 11:10AM	Radius (RDUS) Q3 Earnings Beat Estimates on Tymlos Strength Zacks -17.01%
Nov-05-19 08:05PM	Radius Health (RDUS) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM	Radius Health Announces Third Quarter 2019 Results and Corporate Update GlobeNewswire
11:23AM	Radius Health (NASDAQ:RDUS) Shareholders Booked A 66% Gain In The Last Year Simply Wall St.
Oct-29-19 10:33AM	Radius Health (RDUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-27-19 06:42PM	Heres What Hedge Funds Think About Radius Health Inc (RDUS) Insider Monkey
Oct-24-19 04:34AM	How to invest in biotech stocks like a Nobel Prize winner MarketWatch
Oct-23-19 05:37PM	Radius Health to Announce Third Quarter 2019 Financial Results and Host Webcast Conference Call on November 5, 2019 GlobeNewswire
Sep-13-19 06:03PM	Radius Health to Present Data on Abaloparatide at ASBMR 2019 Annual Meeting GlobeNewswire
Sep-09-19 10:48AM	Will Radius Health Continue to Surge Higher? Zacks
Sep-06-19 09:31AM	Radius Health (RDUS) Up 20.7% Since Last Earnings Report: Can It Continue? Zacks

Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine therapeutics in the areas of osteoporosis and oncology. The company markets TYMLOS, an anabolic agent for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in phase 3 clinical study for the treatment of osteoporosis in men; abaloparatide transdermal patch, a short-wear-time patch, that is in phase 3 clinical study to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in phase 3 clinical study for the treatment of hormone receptor-positive breast cancer; and RAD140, a non-steroidal selective androgen receptor modulator, which is in phase 1A clinical study to treat metastatic breast cancer. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Eisai Co. Ltd.; Duke University; Guardant Health, Inc.; and Teijin Limited. Radius Health, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grausso Sal	Chief Commercial Officer	Feb 25	Sale	18.93	1,322	25,025	11,709	Feb 26 04:36 PM
BIOTECH TARGET N V	10% Owner	Nov 05	Buy	14.26	100,000	1,426,230	7,455,714	Nov 09 11:29 AM
BIOTECH TARGET N V	10% Owner	Sep 14	Buy	11.69	200,000	2,338,680	7,355,714	Sep 16 12:01 PM
BIOTECH TARGET N V	10% Owner	Sep 11	Buy	11.33	199,029	2,255,118	7,155,714	Sep 14 04:03 PM
BIOTECH TARGET N V	10% Owner	Jul 08	Buy	13.21	25,000	330,178	6,956,685	Jul 09 02:40 PM
BIOTECH TARGET N V	10% Owner	Apr 30	Buy	15.75	50,000	787,555	6,931,685	May 04 05:32 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience